Information Provided By: 
Fly News Breaks for February 5, 2020
BHVN
Feb 5, 2020 | 16:30 EDT
Mizuho initiated coverage of Biohaven Pharmaceutical with a Buy rating and $62 price target.
News For BHVN From the Last 2 Days
BHVN
Apr 18, 2024 | 06:06 EDT
The deal size was i creased to $230M in common stock from $200M in common stock and the range was $40.50-$42.00. JPMorgan acted as sole book running manager for the offering.
BHVN
Apr 17, 2024 | 16:10 EDT
BHVN
Apr 17, 2024 | 16:09 EDT
BHVN
Apr 17, 2024 | 11:00 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Soligenix (SNGX),... To see the rest of the story go to thefly.com. See Story Here
